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Abstract
Hypoxia-inducible factor-1 (HIF-1) and its most important subunit, HIF-1a, plays a central role in tumor progression by
regulating genes involved in cancer cell survival, proliferation and metastasis. HIF-1a activity is associated with nuclear
accumulation of the transcription factor and regulated by several mechanisms including modulation of protein stability and
degradation. Among recent advances are the discoveries that inflammation-induced cytokines and growth factors affect
protein accumulation of HIF-1a under normoxia conditions. TNFa, a major pro-inflammatory cytokine that promotes
tumorigenesis is known as a stimulator of HIF-1a activity. To improve our understanding of TNFa-mediated regulation of
HIF-1a nuclear accumulation we screened a kinase-specific siRNA library using a cell imaging–based HIF-1a-eGFP chimera
reporter assay. Interestingly, this systematic analysis determined that depletion of kinases involved in conventional TNFa
signaling (IKK/NFkB and JNK pathways) has no detrimental effect on HIF-1a accumulation. On the other hand, depletion of
PRKAR2B, ADCK2, TRPM7, and TRIB2 significantly decreases the effect of TNFa on HIF-1a stability in osteosarcoma and
prostate cancer cell lines. These newly discovered regulators conveyed their activity through a non-conventional RELB-
depended NFkB signaling pathway and regulation of superoxide activity. Taken together our data allow us to conclude that
TNFa uses a distinct and complex signaling mechanism to induce accumulation of HIF-1a in cancer cells. In summary, our
results illuminate a novel mechanism through which cancer initiation and progression may be promoted by inflammatory
cytokines, highlighting new potential avenues for fighting this disease.
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Introduction
Inflammation is a primary defense process against various
extracellular stimuli, such as viruses, pathogens, foods, and
environmental pollutants. Several studies have shown that
tumorigenesis in many cancers is closely associated with chronic
inflammation. Abnormal cellular alterations that accompany
chronic inflammation such as oxidative stress, gene mutation,
epigenetic change, and inflammatory cytokine release are shared
with carcinogenic processes, which form a critical cross-link
between chronic inflammation and carcinogenesis. Almost 25% of
cancers are reported to occur through chronic inflammation-
related processes [1,2]. The pro-inflammatory regulators such as
TNFa and other cytokines and their receptor networks seem to
play crucial functions in tumorigenesis [3].
Hypoxia-inducible factor-1 (HIF-1) and its most important
subunit, HIF-1a, plays a central role in tumor progression by
regulating genes involved in cancer cell survival, proliferation and
metastasis [4]. HIF-1 is a major component of the oxygen sensing
system that governs cellular responses to decreased oxygen
availability. The hypoxia inducible transcription factor HIF-1 is
a heterodimer composed of the helix-loop-helix-Per-Arnt-Sim
(bHLH-PAS) proteins HIF-1a and the aryl hydrocarbon nuclear
translocator (ARNT) also known as HIF-1b. Transactivation of
HIF-1 transmits a hypoxic signal into a multitude of pathophys-
iological responses by regulation of numerous target genes [4,5].
In addition to hypoxia, more recent evidence suggest that HIF-1
can be accumulated and activated during normoxia by growth
factors, cytokines and other factors associated with inflammation
[5]. Several reports have indicated an important role of TNFa in
regulation of HIF-1a stability and activity [6–8]. However, details
of HIF-1 regulation by TNFa remain unclear.
Here, we describe signaling mechanisms that incite HIF-1a
accumulation in response to TNFa. To improve our understand-
ing of HIF-1 regulation by the cytokine, we screened a kinase-
specific small interference RNA (siRNA) library using a HIF-1a-
eGFP chimera reporter assay under TNFa treatment. This screen
determined that depletion of ADCK2, PRKAR2B, TRIB2 and
TRPM7 most significantly downregulates nuclear accumulation of
HIF-1a in response to the treatment of osteosarcoma cells.
Furthermore, our results suggest that this pathway is also present
in prostate cancer cells. Surprisingly, the mechanism of regulation
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31270of TNFa-elicited HIF-1a accumulation was associated with a non-
conventional NFkB signaling pathway and alleviation of superox-
ide activity. Taken together our data allow us to conclude that
TNFa uses a distinct and complex signaling mechanism to induce
accumulation of HIF-1a.
Results
TNFa is a major inflammatory cytokine reported to be a potent
inducer of HIF-1a nuclear accumulation [5–8]. We examined
several cancer cell lines for HIF-1a accumulation under TNFa
treatment. In our experiments, TNFa produced a significant
increase in nuclear accumulation of HIF-1a in several cancel cell
lines (Fig. 1a). Similarly, TNFa induced nuclear buildup of a HIF-
1a-eGFP chimera protein (Fig. S1a, Fig. 1b,c) in the HIF-
1a_U2OS Redistribution assay based on an osteosarcoma cell
line. The observed effect was concentration- and time-dependent
(Fig. 1b,c). 24 hr incubation with TNFa at 10 ng/mL was selected
for all screening experiments to provide an appropriate window to
study up- and down-regulation of HIF-1a accumulation.
There are two receptors described for TNFa, namely TNF
receptor 1 (TNFR1, p55 receptor) and TNF receptor 2 (TNFR2,
p75 receptor). TNFR1 is ubiquitously expressed while TNFR2 is
mainly expressed in immune cells [9]. Although both receptors
bind TNFa, the main receptor mediating cellular effects in most
cell types is TNFR1. In our experiments, knockdown of the
TNFR1 effectively diminished TNFa-dependent nuclear accumu-
lation of HIF-1a (Fig S1b). TNFa is known to activate multiple
pathways downstream of TNFR1 [9]. To explore the role of
kinases in regulating HIF-1a accumulation under TNFa treat-
ment, we depleted kinases in HIF-1a-U2OS cells using a siRNA
kinase library targeting 788 kinases and then analyzed cellular
accumulation of HIF-1a-eGFP after incubation with TNFa
(Fig. 2a). To minimize siRNA off-target activity we used ON-
TARGETplus version of the human kinases collection of
SMARTpool siRNA reagents [10]. The same kinase library was
screened in a control cell line that expresses only eGFP to subtract
possible non-specific effects. HIF-1a-eGFP screening data were
subjected to Student t-test p-value analysis, Benjamini-Hochberg
multiple comparisons correction [11], and performance ranking
followed by comparison between two independent screening
experiments with a 1.5 fold change threshold. Resulting data
was further compared with data from the counter-screen with cells
expressing eGFP only (1.2 fold change threshold for eGFP only,
Fig S2) and overlapping hits dismissed. Among the 788 kinases
screened by siRNA-mediated silencing, depletion of 77 genes
increased HIF-1a-eGFP accumulation above 2 fold (Table S1) and
depletion of another seven target genes decreased accumulation
under TNFa treatment (Fig. 2a). The genes demonstrating a
siRNA-mediated decrease of HIF-1a accumulation were of
particular interest because these could potentially represent
members of TNFa signaling pathways. These include PRKAR2B,
ADCK2, TRPM7, RIOK2, TRIO, ADRA1B and TRIB2. To confirm
that the decrease in TNFa-induced HIF-1a accumulation in
siRNA-transfected cells was directly related to depletion of selected
targets we repeated this experiment using newly synthesized
siRNA pools (Fig. 2b). Only one out of seven selected hit
candidates was not confirmed: siRNA targeting ADRA1B (data not
shown), which was subsequently omitted from further analysis.
A High Content Analysis approach allows simultaneous
acquisition of multiple data streams from the same set of samples.
We utilized this approach to further analyze the screening data.
Collected data (cell number per field) suggested that none of the
selected siRNAs (PRKAR2B, ADCK2, TRPM7, RIOK2, TRIO, and
TRIB2) produced any effect on cell viability (Fig S3). In addition to
the control of protein stability, HIF-1a function can be regulated
by processes that influence its subcellular localization, e.g.
cytoplasmic vs. nuclear. Simultaneous measurement of HIF-1a
accumulation in the nuclei and cytoplasm revealed that none of
the siRNA targets selected for a decrease in nuclear accumulation
produced an increase in cytoplasmic retention of HIF-1a (data not
shown).
To examine if selected candidate hits can influence TNFa-
mediated accumulation of HIF-1a in other cell types we
determined HIF-1a nuclear buildup in prostate cancer cell lines.
HIF-1a accumulation in LNCaP and DU145 cells was found to be
sensitive to TNFa while PC3, a prostate cell line with significant
invasive potential [12] , demonstrated no such sensitivity (Fig. 1a,).
Depletion of PRKAR2B, ADCK2, TRPM7 and TRIB2 significantly
decreased HIF-1a accumulation in LNCaP, an androgen-sensitive
human prostate adenocarcinoma cell line with low invasive
potential (Fig. 2c). Data similar to U2OS and LNCaP were also
obtained from MCF10a, a non-tumorigenic mammary epithelial
cell line (Fig S4a). In DU145 cells, a prostate cancer cell line with
moderate invasive potential, only TRIB2 depletion was effective in
abrogating TNFa-induced HIF-1a accumulation (Fig S4b). Based
on the above results PRKAR2B, ADCK2, TRPM7 and TRIB2 were
selected for further analysis. siRNA pools targeting these genes
produced concentration-dependent effects on TNFa-stimulated
HIF-1a accumulation in U2OS osteosarcoma cells (Fig. 3a)
In all of our experiments we employed strategies that are known
to diminish siRNA off-target effects: application of chemically
modified siRNA molecules and usage of a siRNA pooling strategy.
To further confirm that the decrease in TNFa-induced HIF-1a
accumulation in siRNA-transfected cells was directly related to on-
target effects of the siRNA, we repeated this experiment using
newly synthesized siRNA pools and four separate siRNA duplexes
(that comprise each pool) to deplete all four cellular targets. These
experiments produced results similar to the screening data – for all
four targets siRNA pools and four individual siRNA duplexes
produced significant decrease in HIF-1a accumulation (.2 fold,
Fig. 3b). Effectiveness of target gene knockdown for selected
siRNA hits was determined using Q-PCR and Solaris probes.
Target gene depletion correlates with the HIF-1a phenotypical
assay - for all four targets siRNA pools used in the screening
campaign and four individual siRNA duplexes demonstrated
potent knockdown (.60%, Fig. 3c). TRPM7 is poorly expressed in
U2OS cells and application of any RNAi reagent effectively
eliminated expression of this target to an undetectable level
(Fig. 3c).
TNFa is known to regulate expression of proteins within its own
signaling cascades. We found that expression of ADCK2 and
TRIB2 mRNA is regulated by TNFa in U2OS cancer cells (Fig
S5). No statistically significant changes were detected for
PRKAR2B and TRPM7.
Recent reports indicate that HIF-1a stability and activity may
be regulated through oxidative stress-sensitive pathways [6,13,14].
Such pathways are also well known regulators of TNFa signaling
[6,15]. To examine a possible role of oxidative stress mechanisms
in TNFa-stimulated HIF-1a accumulation we investigated the
effects of exogenous hydrogen peroxide. While hydrogen peroxide
alone produced a significant increase in HIF-1a accumulation, an
opposite effect was observed on TNFa-pretreated cells (Fig. 4a).
This result suggests possible negative regulation of HIF-1a
accumulation by superoxide, a main source of intracellular
peroxide [16]. We hypothesized that newly discovered positive
regulators of HIF-1a accumulation may control either superoxide
production or a conversion to peroxide. In U2OS cells, TNFa
Mechanism of TNFa -Induced Accumulation of HIF-1a
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superoxide/peroxide conversion enzymes (Fig S6). However,
depletion of the identified positive regulators of HIF-1a accumu-
lation had no effect on expression of MnSOD (Fig S6).
We observed that superoxide scavengers Tiron and TEMPOL
are able to rescue HIF-1a accumulation in TNFa-treated cells
transfected with siRNA against ADCK2, and TRIB2 when
applied in a concentration that does not significantly affect control
cells (Fig. 4b). Cells transfected with PRKAR2B and TRPM7
siRNA were unaffected by superoxide scavengers (Fig. 4b). Taken
together our data suggest that TNFa mediates HIF-1a accumu-
lation through a mechanism that mitigates superoxide production,
and ADCK2, PRKAR2B and TRIB2 are positive regulators of
this mechanism.
Multiple pathways and factors are reported as regulators of
HIF-1a activity in other experimental systems and conditions,
including conventional NFkB, JNK, STAT3, and proteasome
activity [5]. In addition, TNFa is known to induce signaling
through the conventional NFkB pathway [9,17]. Analysis of our
results revealed that depletion of kinases that are necessary for
these pathways produced no negative impact on TNFa-mediated
HIF-1a accumulation. In our experiments, TNFa produced no
significant effect on the STAT3-dependent pathway (Fig S7a). We
hypothesized that because TNFa induces HIF-1a accumulation, it
Figure 1. TNFa-induced nuclear accumulation of the HIF-1a transcription factor. (A) TNFa induced nuclear accumulation of HIF-1a in
LNCaP, DU145, MCF10a and MDA MB231 cancer cell lines. Expression and nuclear accumulation of HIF-1a was determined by immunocytochemistry
imaging as described in Materials and Methods. (B) TNFa-induced stimulation of HIF-1a-eGFP nuclear accumulation in U2OS osteosarcoma in a
concentration dependent manner. (C) TNFa stimulated HIF-1a-eGFP nuclear accumulation in U2OS cells in a time-dependent fashion. All data
(Median+/2MAD) normalized to untreated cells. For each panel, data are representative of two independent experiments performed in triplicate *, **:
Student’s t-test p-value between treated cells and corresponding control group, * - p,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0031270.g001
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as a possible agonist in the U2OS_E6-AP: p53 degradation and
U2OS_SCF-Skp2 E3: p27 degradation Redistribution assays.
Proteasome activity inhibitor MG132 induced accumulation of
eGFP chimeras in both assays while incubation with TNFa had no
effect (Fig S7b,c).
Data from our screening experiments suggest that depletion of
upstream regulators of the JNK pathway results in an increase of
HIF-1a accumulation in response to TNFa treatment (Table S1).
Depletion of the upstream regulators of the conventional NFkB
pathway CHUK, IKBKB or IKBKE do not modulate HIF-1a
accumulation in response to TNFa treatment (Fig S8). Moreover,
siRNA-mediated depletion revealed that NFkB proteins RELA
and NFkB2 may act as negative regulators of such accumulation
because their knockdown produced sharp increase in HIF-1a
accumulation (Fig. 5a). In contrast, NFkB proteins RELB, cREL
and NFkB1 appear to be necessary for TNFa-induced HIF-1a
accumulation because depletion of corresponding genes produced
strong negative effects on accumulation (Fig. 5a). Activation of
NFkB proteins correlates with their intracellular translocation
[17]. We found that in U2OS osteosarcoma cells, TNFa stimulates
translocation of RELB and cREL between the nucleus and
cytoplasm, with RELB being excluded from the nucleus and cREL
accumulating in the nucleus. Similar to depletion of TNFR1,
depletion of TRIB2 and TRPM7 prevented nuclear exclusion of
RELB (Fig. 5b). cREL translocation was not affected by depletion
Figure 2. RNAi Screening to identify regulators of TNFa-induced accumulation of HIF-1a. (A) Representative data set from a kinome-wide
screen of 788 siRNAs. Data (Median+/2MAD) are representative of three individual transfections and are normalized to control siRNA. (B) Selected
siRNA hit candidates were tested in separate experiments. siRNAs targeting ADCK2, RIOK2, PRKAR2B, TRIB2, TRIO and TRPM7 were confirmed as hit
candidates and subjected to further analysis. All data normalized to cells transfected with control siRNA NTC1. (C) Effect of selected siRNA hit
candidates on HIF-1a accumulation in LNCaP prostate cancer cell line. Data (Median+/2MAD) are representative of three independent experiments
performed in triplicate. All data normalized to TNFa-treated cells. *, **: Student’s t-test p-value between treated cells and corresponding control
group, * - p,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0031270.g002
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RELB depletion was attenuated by superoxide scavengers Tiron
and TEMPOL (Fig. 5c). Taken together our results suggest that
TNFa-mediated HIF-1a accumulation may be at least partially
governed by a non-conventional NFkB signaling pathway
activated by TRIB2 and TRPM7.
Discussion
TNFa is well known to evoke multiple signaling mechanisms
where various kinases play irreplaceable roles. Recent advances in
functional genomics and cell imaging techniques allowed us to
perform systematic investigation of possible mechanisms of TNFa-
mediated HIF-1a accumulation. To explore the role of kinases in
regulating HIF-1 activity under treatment with TNF-a,w e
depleted kinases in U2OS osteosarcoma cells using a chemically
modified siRNA kinase library targeting 778 kinases and then
analyzed nuclear accumulation of HIF-1a-eGFP chimera consti-
tutively expressed in these cells. In this assay, TNFa strongly
increased HIF-1a-eGFP protein accumulation (Fig. 1b,c).
Under normal physiological conditions HIF-1a accumulation is
heavily repressed by several regulatory pathways. Kinases and
Figure 3. Validation of siRNAs targeting selected hit candidates. (A) Selected siRNAs decrease TNFa-mediated HIF-1a accumulation in a
concentration dependent maner. (B) siRNA pools and individual siRNA molecules produced comparable effects on HIF-1a accumulation. (C) siRNA
pools and individual siRNA molecules for the selected hit candidates provide effective target gene depletion. U2OS cells were incubated with TNFa
for 24 hr. All data normalized to cells transfected with control siRNA NTC1. Data are representative of two independent experiments, three
(A,B,Median+/2MAD) or two (C, Mean+/2STDEV) individual transfections each.
doi:10.1371/journal.pone.0031270.g003
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pathways. Thus, we expected that the majority of siRNA hit
candidates would provide a release from the repression of HIF-1a
accumulation. Indeed, among the 788 kinases screened by siRNA-
mediated silencing, depletion of 6 kinases significantly decreased
HIF-1a accumulation and depletion of another 89 kinases
increased HIF-1 activity in cells treated with TNFa (Fig. 2a,b
and Table S1).
To some extent, our data recapitulates previous findings
regarding negative regulators of HIF-1a activity [18]. It was
reported that SMG-1 suppresses HIF-1 activity under hypoxic
conditions and that siRNA-mediated depletion of the gene product
significantly increases activity of a HIF-1a-sensitive reporter [18].
Results of our screening experiments indicate that depletion of
SMG-1 specifically up-regulates TNFa-induced HIF-1a accumu-
lation (data not shown).
Several pathways were found to be significantly over-represent-
ed in the group of 77 negative regulators: 16 genes represents
GO:0007049 cell cycle (NEK4, TAF1L, CKS2, TTK, MAP3K8,
PIM2, TLK1, PPP2CA, NEK9, PRKAG1, NEK6, PLK4, DGKZ,
DUSP1, PIM1, PRKAA2), 11 genes represents GO:0000165
MAPKKK signaling cascade (PPP2CA, RPS6KA3, DUSP5, MAP-
KAPK3, MAPK8IP3, MAP4K5, DUSP2, MAPK11, MAP4K1,
DUSP1, MAP3K9), and four kinases represent GO:0007254 JNK
cascade system (MAP4K1, MAP4K5, MAPK8IP3, MAP3K9) (Table
S1). These data suggest that such pathways may oppose TNFa
signaling and inhibit HIF-1a accumulation.
Depletion of several target genes inhibit TNFa-mediated HIF-
1a accumulation (Fig. 2). These genes may represent one or more
TNFa signaling mechanisms, and are of particular interest. In our
screening campaign we identified six targets of this kind (Fig. 2b).
Furthermore, our results suggest that four of these genes - ADCK2,
PRKAR2B, TRIB2 and TRPM7 - seem to regulate HIF-1a
accumulation in multiple cancer cell lines (Fig. 2, Fig S4). All
four genes were previously described in connection with regulation
of cancer cell proliferation and motility but existing data did not
suggest their participation in TNFa signaling [19–23]. The
functions of ADCK2 protein are not yet clear. It is not known if
it has protein kinase activity and what type of substrate it would
phosphorylate. Several reports established a connection of ADCK2
to cancer cell proliferation and motility [20]. PRKAR2B encodes
the cAMP-dependent protein kinase type II-beta regulatory
subunit. The cAMP-dependent protein kinase A (PKA) is a
ubiquitous serine/threonine protein kinase. PKA is accepted as a
major mediator of intracellular cAMP signals in eukaryotes. To
date, a large number of cytoplasmic and a few nuclear PKA
Figure 4. TNFa-induced regulation of HIF-1a is governed by intracellular superoxide accumulation. (A) While addition of hydrogen
peroxide (100 mM, 3 hr incubation) can stimulate HIF-1a accumulation, it diminishes such accumulation in TNFa-treated cells (21 hr incubation with
TNFa only followed by 3 hr incubation in the presence of both TNFa and hydrogen peroxide). Data (Median+/2MAD) normalized to cells transfected
with control siRNA NTC1 and treated with DMSO. (B) Superoxide scavengers rescue HIF-1a accumulation in cells transfected with siRNAs targeting
ADCK2 and TRIB2 but not PRKAR2B or TRPM7. Cells were treated with TNFa similar to (A) and incubated with Tiron (0.3 mM), 4-hydroxy-TEMPO
(0.1 mM) or DMSO (vehicle control) for 3 hr. Data (Median+/2MAD) normalized to cells transfected with control siRNA NTC1 and treated with DMSO.
For each panel data are representative of two independent experiments performed in quadruplicate. *, **: Student’s t-test p-value between treated
cells and corresponding control group, * - p,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0031270.g004
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PRKAA1 (the catalytic subunit of the PKA) also produced a
decrease in HIF-1a accumulation although to a lower extent than
PRKAR2B depletion (data not shown). Further studies are
necessary to clarify the exact role of PKA in TNFa-stimulated
HIF-1a accumulation. Although the molecular function of TRIB2
(Tribbles homolog 2) is still unclear, it has been identified as a
potential driver of lung tumorigenesis and a myeloid oncogene
[21,22]. TRPM7 is a ubiquitously expressed and constitutively
active divalent cation channel. It provides a mechanism for Mg2+
entry and thus it is essential for cell survival and proliferation
[19,24].
Key regulators of TNFa signaling pathways are reactive oxygen
species (ROS; e.g., superoxide, hydrogen peroxide, and hydroxyl
radical) [6,15]. ROS have been suggested to modulate TNFa
signaling, providing both positive and negative regulation of the
NFkB system downstream of TNFR1 depending on the
experimental system and conditions [6,25]. Our results imply that
hydrogen peroxide suppresses TNFa-mediated HIF-1a accumu-
lation (Fig. 4a). These data suggest that the source of intracellular
hydrogen peroxide, superoxide anion may inhibit TNFa-mediated
HIF-1a accumulation as well. We hypothesized that the newly
described regulators of the accumulation may elicit their effect
through modulation of superoxide production. Indeed, alleviation
of superoxide anion activity rescues HIF-1a accumulation on the
background of depletion of ADCK2 and TRIB2 (Fig. 4b). All
these results suggest that TNFa-induced HIF-1a accumulation
may be regulated by a superoxide sensitive pathway and that the
above three proteins may be involved in negative regulation of
superoxide production (Fig. 6).
Figure 5. TNFa induces accumulation of HIF-1a through a non-conventional NFkB-dependent pathway. (A) Depletion of NFkB1, RELB
and cREL but not NFkB2 and RELA interfere with HIF-1a accumulation in TNFa-treated cells. (B) Depletion of ADCK2 and PRKAR2B prevents
accumulation of RELB in the nuclei of TNFa-treated cells. (C) Effect of depletion of RELB is rescued by ROS scavengers. Cells were treated similar to
Fig. 4C. (D) All data (Median+/2MAD) is normalized to cells transfected with control siRNA NTC1 treated with TNFa (10 ng/ml, 24 hr). The data are
representative of two independent experiments performed in triplicate. *, **: Student’s t-test p-value between treated cells and corresponding
control group, * - p,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0031270.g005
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NFkB signaling cascades are major mechanisms that convey
effects of TNFa on intra-cellular physiology [26]. Our screening
results suggest that depletion of positive regulators upstream of
conventional NFkB - IKK-a (CHUK), IKK-b (IKKB) or IKK-e
(IKBKE) - produced no negative impact on HIF-1a nuclear
accumulation (Fig S8).
Also, we found that depletion of RELA and NFKB2 results in a
significant upregulation of HIF-1a accumulation while depletion
of RELB, cREL and NFKB1 produces a decrease in HIF-1a
accumulation. Such a decrease can be rescued by mitigation of
superoxide anion activity (Fig. 5). Furthermore, depletion TRIB2
and TRPM7 was found to prevent intracellular translocation of
RELB upon treatment with TNFa. These findings allowed us to
speculate that TNFa may regulate HIF-1a accumulation through
both conventional and non-conventional NFkB pathways. The
actual amount of accumulated HIF-1a will then depend on a
balance between different TNFa-induced NFkB pathways. The
proposed model seems to be in line with the known complexity of
inflammation-cancer relationships [3].
Taken together our results suggest that TNFa-induced HIF-1a
buildup is regulated by a several pathways (Fig. 6). At least in part,
TNFa may convey its effect through TNFR1 receptor signaling
leading to a non-conventional NFkB-dependent mechanism that
negatively regulates production of reactive oxygen species. This
mechanism appears to be controlled by ADCK2 and TRIB2.
TRPM7 appears to stimulate RELB translocation, but its
depletion phenotype can not be rescued by alleviation of
superoxide activity. Thus TRPM7 may represent an independent
pathway of regulation of HIF-1a accumulation. Further studies
are necessary to understand the greater complexity of TNFa-
dependent stimulation of HIF-1a nuclear accumulation and its
role in tumorigenesis and tumor progression.
Materials and Methods
Cell lines
PC3, DU145, LNCaP, MCF10a, MDAMB-231, MCF7,
SW480 and HepG2 were obtained from ATCC and maintained
according to recommended protocols.
HIF-1a_U2OS Redistribution assay was used in screening
campaign to monitor HIF-1a nuclear accumulation: recombinant
U2OS cells stably expressing human HIF-1a (NM_001530) fused
to the C-terminus of enhanced green fluorescent protein (eGFP).
U2OS cells are adherent epithelial cells derived from human
osteosarcoma. Expression of eGFP-HIF-1a is controlled by a
standard CMV promoter and continuous expression is maintained
by addition of G418 to the culture medium according to
manufacturer protocol. U2OS stable cell line that expresses eGFP
only was used as a subtraction control in screening campaign.
In addition to HIF-1a_U2OS the effect of TNFa treatment was
tested in three separate Thermo Fisher Scientific Redistribution
Assays: the STAT3_U2OS Redistribution Assay, the E6-AP: p53
degradation Redistribution Assay (U2OS), and the SCF-Skp2 E3
Ligase: p27 degradation Redistribution Assay (U2OS). Assays
were performed according to manufacturer protocols for all
reference compounds. For TNFa-treatment, each assay cell line
was treated for 24 hours at 37uC with TNFa at the following
concentrations: 80 ng/mL, 40 ng/mL, 20 ng/mL, 10 ng/mL,
5 ng/mL, 2.5 ng/mL, 1.25 ng/mL, and 0.63 ng/mL. Each
TNFa titration was performed in quadruplicate on 96-well assay
plates, and each assay plate was performed in triplicate. After
TNFa treatment, plates were fixed, stained with Hoechst 33258,
and imaged as described below. TNFa was purchased from R&D
Systems, hydrogen peroxide, Hoechst 33258, Tiron and 4-
hydroxy-TEMPO (TEMPOL) were purchased from Thermo
Fisher Scientific.
Transfection
All cell lines were transfected with Dharmafect (DF) tranfection
reagents (Thermo Fisher Scientific): DF1 (HepG2, MCF7,
MCF10A), DF2 (SW480), DF3 (HIF-1a_U2OS, DU145, LNCaP,
PC3) and DF4 (MDA-MB-231). The screening campaign in HIF-
1a_U2OS and control cells was performed using an ON-
TARGETplus version of the human kinases collection of
SMARTpool siRNA regents kinase library targeting 788 kinases
(Thermo Fisher Scientific). ON-TARGETplus Non-Targeting
Control 1(NTC1) siRNA pool was used as a negative control
and for normalization purposes. siRNAs targeting TNFR1 and
HIF-1a were used as positive controls for transfection efficiency
during screening campaign and other transfection experiments.
Immunocytochemistry
Cultures grown and treated on 96-well plates were fixed in a 4%
PFA solution containing 16 Hoechst 33258 (Thermo Fisher
Scientific) for 15 min, followed by two washes with PBS. Plates
were incubated overnight at 4uCi n1 6Blocking Buffer (Thermo
Fisher Scientific) diluted in PBS, followed by incubation with
primary antibodies diluted in 16Blocking Buffer for 1 h at RT.
Primary antibodies and dilutions were as follows: anti-RelA/p65
(Santa Cruz), 1:50; anti-RelB (R&D Systems), 1:40; anti-cRel (Cell
Signaling Technologies), 1:50, anti NFkB1/p105 (Abcam), 1:200.
Plates were washed twice with PBS, followed by incubation with
secondary antibody diluted in 16 Blocking Buffer for 1 hour at
Figure 6. Proposed model for TNFa-induced nuclear accumu-
lation of HIF-1a. Our results suggest that TNFR1 receptor may convey
its effect through a complex mechanism that includes a non-
conventional NFkB-dependent pathway. This mechanism may nega-
tively regulate production of reactive oxygen species and appears to be
controlled by TRIB2, ADCK2 and PRKAR2B.
doi:10.1371/journal.pone.0031270.g006
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follows: Goat Anti-Mouse IgG (H+L), DyLight 649 Conjugated
(Thermo Fisher Scientific, MA), 1:200; Goat Anti-Rabbit IgG
(H+L), DyLight 649 Conjugated (Thermo Fisher Scientific, MA),
1:200. Plates were washed three times with PBS and sealed for
imaging. HIF-1a and MnSOD were detected using the Cellomics
HIF-1a and MnSOD Induction HCS Reagent Kits (Thermo
Fisher Scientific) according to manufacturer’s instructions.
Cell Imaging
Imaging of harvested cells was performed using the ArrayScanH
VTI HCS Reader and CellInsight
TM Personal Cell Imager
(Thermo Fisher Scientific). eGFP fluorescence was analyzed using
the Molecular Translocation BioApplication (Thermo Fisher
Scientific). Immunofluorescence was analysed using the Compart-
mental Analysis BioApplication (Thermo Fisher Scientific). Images
were acquired using a 106 objective. Images and data were
collected for three fields per well.
Gene expression analysis
The SV 96 Total RNA Isolation System (Promega, Madison,
WI, catalog #Z3505) was used for total RNA purification. The
Nanodrop (Thermo Fisher Scientific) was used to determine
average concentration of the RNA preps. After isolation, total
RNA was frozen at 280uC for storage until further use. Total
RNA was thawed once for the RT step, which 5 mL of RNA was
used in all cDNA reactions. Verso cDNA Synthesis Kit (Thermo
Scientific, catalog #AB-1453) was used for the cDNA synthesis
step. cDNA reactions were set up according to the supplier’s
protocol in a total of 20 mL reactions. Random hexamers and
oligo-dT primers in a ratio of 3 to 1 were used in cDNA reactions.
Cycling conditions were 42uC for 30 minutes then an inactivation
step of 95uC for 2 minutes. No reverse transcriptase enzyme and
no template controls were used for each RT run and each gene
assay to determine presence of contamination, which all came up
negative. Expression of ADCK2 (NM_052853), PRKAR2B
(NM_002736), RIOK2 (NM_018343), TRIB2 (NM_021643,
TRIO (NM_007118), and TRPM7 (NM_017672) was determined
by qRT-PCR in both TNFa treated and untreated cells and
transfected cells. Corresponding Thermo Scientific Solaris Human
qPCR Gene Expression Assays were purchased from Thermo
Scientific - ADCK2 #AX-005304-00, PRKAR2B #AX-007673-
00, RIOK2 #AX-005002-00, TRIB2 #AX-005391-00, TRIO
#AX-005047-00, and TRPM7 #AX-005393-00. PPIB Solaris
Human qPCR Gene Expression Assay (catalog #AX-004606-00)
was used to determine PPIB (NM_000942) expression for sample
input normalization and analysis of relative expression of the
specific genes. All Solaris assays listed do not span an exon-exon
boundary or map to any pseudogenes. Either the assay probes or
primers cross a splice site. cDNA was diluted 3-fold, and 3 mLo f
the dilution was the cDNA input for the qPCR reactions. The
Thermo Scientific Solaris qPCR Gene Expression Master Mix
(Thermo Scientific, catalog #AB-4350) was used for the qPCR
step for a 15 mL final reaction volume, and the Ct values used for
further analysis were obtained using the Roche Light Cycler 480
(Roche). All qPCR reactions were set up according to the
supplier’s protocol (1 cycle at 95uC for 15 minutes, then 95uC for
15 seconds followed by 60uC for 1 minute for 40 cycles). In all
transfection experiments, relative gene expression was normalized
to ON-TARGETplus Non-Targeting Pool transfected siRNA
controls (Thermo Scientific) for each plate separately. All
treatments were tested in biological triplicates. Additional
information is presented in Table S2.
Gene Ontology analysis
L2L (University of Washington) and DAVID (NIAID) tools
were used to analyze RNAi screening data.
Supporting Information
Figure S1 Effect of TNFa and transfection controls on
HIF-1a-EGFP translocation in U2OS osteosarcoma cells.
(A) Exemplary images of HIF-1a _EGFP translocation in control-
and TNFa-treated U2OS cells. (B) Effect of TNFa and
transfection controls on HIF-1a -EGFP translocation in U2OS
osteosarcoma cells. All data (Median+/2MAD) normalized to
cells transfected with control siRNA NTC1. Data are represen-
tative of three independent experiments, six individual transfec-
tions each. *, **: Student’s t-test p-value between treated cells and
corresponding control group, * - p,0.01, ** - p,0.05.
(TIF)
Figure S2 Schematic description of selection of hit
candidates for positive regulation of HIF-1a accumula-
tion. Screening data were subjected to Student t-test p-value analysis
followed by Benjamini-Hochberg multiple comparisons correction, and
performance ranking (top 10% selected). This analysis was followed by
comparison between two independent screening experiments. Resulting
data were further compared with data from the counter-screen with
cells expressing eGFP only. Finally, only hits demonstrating fold change
above 1.5 fold were selected for further experiments.
(TIF)
Figure S3 Effect of selected siRNAs on cell viability of
U2OS osteosarcoma cells treated with TNFa. siRNA
targeting ADCK2, RIOK2, PRKAR2B, TRIB2, TRIO and TRPM7
were transfected into U2OS osteosarcoma cell line. Cells were
treated with TNFa (10 ng/mL) for 24 hr before harvesting. Cell
number per field was determined 72 hr after transfection. PLK1
siRNA was used as positive control. All data normalized to cells
transfected with control siRNA NTC1. Data (Median+/2MAD)
are representative of two independent experiments performed in
triplicate. All data normalized to TNFa-treated cells.
(TIF)
Figure S4 Selected siRNAs decrease accumulation of
HIF-1a in MCF10a, and DU145 cells incubated with
TNFa. (A) Effect of selected siRNA hit candidates on HIF-1a
accumulation in MCF10a breast epithelial cell line. (B) Effect of
selected siRNA hit candidates on HIF-1a accumulation in DU145
prostate cancer cell line. Data (Median+/2MAD) are represen-
tative of two independent experiments performed in triplicate. All
data normalized to TNFa-treated cells.
(TIF)
Figure S5 Effect of TNFa on expression of selected
target genes in U2OS osteosarcoma cells. U2OS cells were
incubated with TNFa for 24 hr. All data (Median+/2MAD)
normalized to cells transfected with control siRNA NTC1. Data
are representative of two independent experiments, two individual
transfections each.
(TIF)
Figure S6 Effect of selected siRNAs on expression of
MnSOD in U2OS osteosarcoma cells treated with TNFa.
siRNA targeting ADCK2, RIOK2, PRKAR2B, TRIB2, TRIO and
TRPM7 were transfected into the U2OS osteosarcoma cell line.
Cells were harvested 72 hr after transfection. Cells were treated
with TNFa (10 ng/mL) for 24 hr before harvesting. All data
normalized to untreated cells transfected with control siRNA
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ed with control siRNA NTC1.
(TIF)
Figure S7 Effect of selected siRNAs on nuclear translo-
cation of STAT3, degradation of p27, and degradation of
p53 in U2OS osteosarcoma cells. Cells were incubated with
TNFa (10 ng/mL) for 24 hr. Nuclear translocation of STAT3 (A),
degradationof p27(B), and degradation of p53(C) were determined
asdescribed inMaterialsandMethods. Alldata (Median+/2MAD)
normalized to cells transfected with control siRNA NTC1.
(TIF)
Figure S8 Effect of CHUK, IKBKB and IKBKE siRNAs
on HIF1a accumulation in U2OS osteosarcoma cells.
siRNA targeting CHUK, IKBKB and IKBKE were transfected
into U2OS osteosarcoma cells. Cells were harvested 72 hr after
transfection. Cells were treated with TNFa (10 ng/mL) for 24 hr
before harvesting. All data normalized to untreated cells
transfected with control siRNA NTC1. All data normalized to
cells transfected with control siRNA NTC1. Data (Median+/
2MAD) are representative of two independent experiments
performed in triplicate. All data normalized to TNFa-treated cells.
(TIF)
Table S1 RNAi-based screening identified negative
regulators of TNFa-mediated accumulation of HIF-1a.
Fold change values indicate increase in HIF-1a accumulation
under TNFa treatment in cells transfected with corresponding
siRNA relative to NTC1 control siRNA.
(XLS)
Table S2 Additional information on Solaris RT-qPCR
assay.
(XLS)
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